Skip to main navigation Skip to search Skip to main content

Mycophenolate mofetil is an effective and safe option for the management of systemic sclerosis-associated interstitial lung disease: Results from the Australian Scleroderma Cohort Study

  • Claire E. Owen
  • , Gene Siew Ngian
  • , Kathleen Elford
  • , Owen A. Moore
  • , Wendy Stevens
  • , Mandana Nikpour
  • , Candice Rabusa
  • , Susanna M. Proudman
  • , Janet Roddy
  • , Jane Zochling
  • , Catherine L. Hill
  • , Allan Sturgess
  • , Kathleen Tymms
  • , Peter Youssef
  • , Joanne Sahhar*
    • *Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

47 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Mycophenolate mofetil is an effective and safe option for the management of systemic sclerosis-associated interstitial lung disease: Results from the Australian Scleroderma Cohort Study'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science

Medicine and Dentistry